Corbus Pharmaceuticals Holdings, Inc.

NasdaqCM:CRBP Stock Report

Market Cap: US$510.1m

Corbus Pharmaceuticals Holdings Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqCM:CRBP Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
08 Mar 24BuyUS$23,327,560Cormorant Asset Management, LPCompany550,000US$45.96
02 Feb 24BuyUS$14,250,000Cormorant Asset Management, LPCompany750,000US$19.00
26 Jan 24BuyUS$9,111,941Cormorant Asset Management, LPCompany282,632US$38.49

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of CRBP?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders21,8610.208%
Private Companies343,8393.27%
General Public662,2136.3%
Hedge Funds2,584,27124.6%
Institutions6,895,05365.6%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 149.3%.


Top Shareholders

Top 25 shareholders own 83.03% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
19.3%
Cormorant Asset Management, LP
2,025,000US$98.3m0%4.46%
5.32%
Ikarian Capital, LLC
559,271US$27.2m185%7.52%
4.16%
The Vanguard Group, Inc.
437,264US$21.2m144%no data
4.09%
RA Capital Management, L.P.
430,182US$20.9m0%0.26%
4.06%
Tang Capital Management, LLC
426,220US$20.7m0%2.13%
3.95%
Adage Capital Management, L.P.
415,000US$20.1m-47.9%0.04%
3.85%
Octagon Capital Advisors LP
405,000US$19.7m0%2.52%
3.8%
Paradigm Biocapital Advisors LP
399,658US$19.4m0%0.68%
3.7%
Point72 Asset Management, L.P.
388,676US$18.9m0%0.13%
3.51%
Citadel Advisors LLC
369,167US$17.9m0%0.02%
3.26%
K2 Healthventures Equity Trust LLC
342,113US$16.6m0%no data
3.23%
Janus Henderson Group plc
339,074US$16.5m0%0.01%
3.09%
Millennium Management LLC
324,902US$15.8m0%0.01%
2.47%
Assenagon Asset Management S.A.
259,456US$12.6m0%0.02%
2.1%
BlackRock, Inc.
220,862US$10.7m172%no data
1.83%
T. Rowe Price Group, Inc.
192,495US$9.3m0%no data
1.76%
Barclays PLC Private Banking & Investment Banking Investment
185,148US$9.0m0%0.01%
1.64%
Morgan Stanley, Investment Banking and Brokerage Investments
171,976US$8.3m8,260%no data
1.48%
Boothbay Fund Management, LLC
156,013US$7.6m275%0.23%
1.26%
Walleye Capital LLC
132,584US$6.4m0%0.04%
1.18%
Schonfeld Strategic Advisors LLC
124,273US$6.0m0%0.04%
1.04%
Geode Capital Management, LLC
108,808US$5.3m185%no data
1.01%
Goldman Sachs Group, Investment Banking and Securities Investments
106,378US$5.2m0%no data
0.99%
Altitude Crest Partners Inc.
103,703US$5.0m0%2.21%
0.96%
Prosight Management, LP
100,617US$4.9m0%1.32%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.